GNH USA

Europe — EMA

Ovamex Theramex (Ganirelix)

GNH USA supplies Ovamex Theramex (Ganirelix), a GnRH antagonist for controlled ovarian stimulation and prevention of premature LH surge in IVF cycles.

Ganirelix

Request sourcing

1
Pack/s

What is Ganirelix?

Ganirelix, the active ingredient in Ovamex Theramex, is a GnRH antagonist presented as an injectable solution for subcutaneous use. It is employed in controlled ovarian stimulation protocols within assisted reproductive technology to prevent premature luteinizing hormone surges and to optimise egg retrieval in women undergoing in‑vitro fertilisation.

GNH USA supplies Ovamex Theramex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable cold‑chain logistics for injectable products.

What is Ganirelix used for?

Ganirelix is a GnRH antagonist used in assisted reproductive technology to manage ovarian stimulation.

- Controlled ovarian stimulation: Enables precise timing of follicular development and improves oocyte yield during ART cycles. - Prevention of premature LH surge: Suppresses luteinizing hormone release to avoid early ovulation in IVF protocols.

What are the side effects of Ganirelix?

Ganirelix may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Injection site pain or erythema: mild discomfort at the subcutaneous injection site. - Nausea: occasional feeling of queasiness. - Headache: mild to moderate tension‑type headache. - Hot flashes: transient warmth and sweating. - Abdominal discomfort: mild cramps or bloating. - Mild ovarian cyst formation: small functional cysts that resolve spontaneously.

Serious or Rare Side Effects: - Ovarian hyperstimulation syndrome: severe ovarian enlargement with fluid shifts. - Anaphylactic reaction: rare but potentially life‑threatening allergy. - Severe abdominal pain: may indicate complications such as ovarian torsion. - Thromboembolic events: rare clot formation in veins or arteries.

What precautions apply to Ganirelix?

When using Ganirelix, clinicians should observe several safety measures.

- Assess ovarian response: monitor follicular growth with serial ultrasound. - Avoid in patients with hypersensitivity: do not administer to individuals allergic to ganirelix or formulation excipients. - Use under specialist supervision: restrict to ART programmes managed by qualified reproductive specialists. - Consider renal or hepatic impairment: increase monitoring frequency in patients with organ dysfunction. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Ganirelix interact with?

Ganirelix can interact with other agents used in fertility treatment and hormonal regulation.

Major Interactions (Avoid): - Co‑administration with GnRH agonists: may diminish antagonist efficacy. - Concurrent hormonal contraceptives: can interfere with intended LH/FSH suppression.

Moderate Interactions (Monitor Closely): - Use with other fertility drugs (e.g., hCG): monitor for signs of ovarian hyperstimulation. - Concomitant anticoagulants: observe for altered bleeding risk. - Antihistamines: may mask mild injection‑site reactions.

Frequently asked questions

What is Ovamex Theramex used for?+
Ovamex Theramex contains ganirelix, a GnRH antagonist used in assisted reproductive technology. It suppresses the natural luteinizing hormone surge, allowing clinicians to control ovarian stimulation, improve timing of egg retrieval, and reduce the risk of premature ovulation during in‑vitro fertilisation cycles.
How does ganirelix work?+
Ganirelix competitively blocks GnRH receptors on the pituitary gland, preventing the release of luteinizing hormone (LH) and follicle‑stimulating hormone (FSH). By inhibiting these hormones, the drug stops the spontaneous LH surge that would otherwise trigger ovulation, giving physicians precise control over follicular development in IVF protocols.
What is the usual dose of Ovamex Theramex?+
The dosing regimen for Ovamex Theramex is determined individually by the treating reproductive specialist. The prescriber selects the amount, timing, and number of subcutaneous injections based on the patient’s ovarian response, treatment protocol, and clinical goals.
Is Ovamex Theramex safe during pregnancy or breastfeeding?+
Ganirelix is intended for use before pregnancy to facilitate egg retrieval and is not administered during an established pregnancy. Safety data for use in pregnant or breastfeeding women are lacking, so the product should be avoided in these populations unless a specialist determines a clear benefit outweighs potential risks.
How do I order Ovamex Theramex from GNH USA?+
To request Ovamex Theramex, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details—including cold‑chain handling for injectables—and the necessary import documentation.
How does Ovamex Theramex compare with other GnRH antagonists?+
Ovamex Theramex (ganirelix) and other GnRH antagonists such as cetrorelix share the same mechanism of competitively blocking GnRH receptors. Both provide rapid LH suppression, but formulation differences, dosing schedules, and manufacturer‑specific excipients may influence convenience, storage requirements, and cost. Clinical choice often depends on protocol preferences and supply considerations.
How should Ovamex Theramex be stored and handled?+
Ovamex Theramex must be stored refrigerated at 2‑8 °C. Keep the vial in its original packaging, protect it from light, and avoid freezing or shaking. If the product reaches room temperature for a short period during administration, it may be used, but it should be returned to refrigeration promptly.
How is Ovamex Theramex administered?+
The medication is supplied as a sterile injectable solution for subcutaneous injection. A qualified healthcare professional draws the prescribed volume into a syringe, selects an appropriate injection site (typically the abdomen or thigh), cleans the skin with an antiseptic, and administers the dose according to the clinic’s protocol.
What are the most serious risks associated with Ovamex Theramex?+
The most serious adverse events include ovarian hyperstimulation syndrome (OHSS), which can cause severe abdominal pain, fluid accumulation, and thromboembolic complications, and rare anaphylactic reactions that require immediate medical attention. Patients should be monitored closely for signs of these conditions during and after treatment.
Who should not use Ovamex Theramex?+
Ovamex Theramex is contraindicated in individuals with known hypersensitivity to ganirelix or any formulation component. It should not be used in men, in women not undergoing assisted reproductive procedures, or in patients where ovarian stimulation is medically inadvisable, such as those with uncontrolled endocrine disorders.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Ganirelix
Route
Subcutaneous Use
Manufacturer
Theramex Ireland Limited
Origin
EU

Related products

Astarté

Astarté

Ganirelix

Gp-Pharm S.A.
EU
Astarté

Astarté

Ganirelix

Gp-Pharm S.A.
EU
Fyremadel

Fyremadel

Ganirelix

Sun Pharmaceutical Industries Europe B.V.
EU
Fyremadel

Fyremadel

Ganirelix

Sun Pharmaceutical Industries Europe B.V.
EU